Issue 2-2018

  • Issue 2-2018

    Letter from the Editor
    Magnus Gisslén

    Hepatitis at the ILC
    Per Lundblad

    Satellite symposiums at the European ILC
    Per Lundblad

    BHIVA - events
    Rageshri Dhairyawan

    What’s new in hepatitis? A report from the International Liver Congress in Paris
    Johannes Vermehren

    Archived nucleos(t)ide resistance mutations in the era of high genetic barrier antiretrovirals: still matter?
    José R Arribas

    The new drugs in later lines of therapy
    Graeme Moyle

    Notes 2018
    Leo Flamholc